Genetic Analysis

Norway
Oslo, Oslo, Norway, 0510

Company profile

Genetic Analysis company profile

Genetic Analysis AS (GA) has the goal of being a leader within the field of molecular diagnostics of diseases related to gut imbalances. By utilizing the DNA-based GA-map™ array technology, profiles of a patient’s gut microbiota is quickly generated and can be related to various health conditions. Genetic Analysis has developed a DNA-based technology platform that allows for simultaneous analysis of a large number of similarities (but not identical) gene fragments in one reaction. The company’s focus is to utilize this technology platform to identify variations in the hundreds of different bacteria that exist in the gut (large and small intestine). The GA - map makes it possible, for the first time, to offer a diagnostic solution – including early detection - for many diseases that are affected by imbalances in the gut microbiota. Genetic Analysis will offer kits and services for a wide range of applications.

Business identity

Contact email
[email protected]
Phone number
+47 48 32 16 10
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2008-01-01

Headquarters

Headquarters
Oslo, Oslo, Norway
Postal code
0510
Country code
NO
Continent
Europe

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
3
Total equity funding
$4.5M
Last funding
Post IPO Equity / $1.3M / 2025-06-05
Last equity funding
Post IPO Equity / $1.3M
Investors
26
Lead investors
2
Articles
45
Exited on
2021-10-29

Founders and investors

Lead investors

TeleVenture ManagementTore Grøttum

Investors

Bio-Rad LaboratoriesKess InvestmentsLJM Lind JensenMuen InvestTeleVenture Management